To get ahead of variants, Covid drug makers use evolution as guide- STAT

To get ahead of variants, Covid drug makers use evolution as guide- STAT: Some monoclonal antibodies now used to treat patients in the U.S. aren’t great at gumming up the machinery of some new SARS-2 variants.